Search by Drug Name or NDC

    NDC 65862-0847-01 CLOZAPINE 200 mg/1 Details

    CLOZAPINE 200 mg/1

    CLOZAPINE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is CLOZAPINE.

    Product Information

    NDC 65862-0847
    Product ID 65862-847_b2666ba9-e113-4156-86b8-7bde5b9ce216
    Associated GPIs 59152020000340
    GCN Sequence Number 046416
    GCN Sequence Number Description clozapine TABLET 200 MG ORAL
    HIC3 H7T
    HIC3 Description ANTIPSYCHOTIC,ATYPICAL,DOPAMINE,SEROTONIN ANTAGNST
    GCN 31672
    HICL Sequence Number 004834
    HICL Sequence Number Description CLOZAPINE
    Brand/Generic Generic
    Proprietary Name CLOZAPINE
    Proprietary Name Suffix n/a
    Non-Proprietary Name CLOZAPINE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 200
    Active Ingredient Units mg/1
    Substance Name CLOZAPINE
    Labeler Name Aurobindo Pharma Limited
    Pharmaceutical Class Atypical Antipsychotic [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206433
    Listing Certified Through 2024-12-31

    Package

    NDC 65862-0847-01 (65862084701)

    NDC Package Code 65862-847-01
    Billing NDC 65862084701
    Package 100 TABLET in 1 BOTTLE (65862-847-01)
    Marketing Start Date 2016-11-29
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 1.42924
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description CLOZAPINE 200 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis